Tasos Konidaris - Net Worth and Insider Trading

Tasos Konidaris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tasos Konidaris owns 4 companies in total, including Kadmon Holdings Inc (KDMN) , Amneal Pharmaceuticals Inc (AMRX) , and Pernix Therapeutics Holdings Inc (PTXTQ) among others .

Click here to see the complete history of Tasos Konidaris’s form 4 insider trades.

Insider Ownership Summary of Tasos Konidaris

Ticker	Comapny	Transaction Date	Type of Owner
KDMN	Kadmon Holdings Inc	2020-05-13	director
AMRX	Amneal Pharmaceuticals Inc	2020-03-12	SVP and CFO
PTXTQ	Pernix Therapeutics Holdings Inc	2016-05-26	director
		2012-07-05	director

Tasos Konidaris Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tasos Konidaris Ownership Network

Ownership Network List of Tasos Konidaris

No Data

Ownership Network Relation of Tasos Konidaris

Tasos Konidaris Owned Company Details

What does Kadmon Holdings Inc do?

Who are the key executives at Kadmon Holdings Inc?

Tasos Konidaris is the director of Kadmon Holdings Inc. Other key executives at Kadmon Holdings Inc include director & President & CEO Harlan Waksal , Executive Vice President & CMO John L Ryan , and EVP & Chief Financial Officer Steven Meehan .

Kadmon Holdings Inc (KDMN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kadmon Holdings Inc Insider Transactions

No Available Data

What does Amneal Pharmaceuticals Inc do?

Who are the key executives at Amneal Pharmaceuticals Inc?

Tasos Konidaris is the SVP and CFO of Amneal Pharmaceuticals Inc. Other key executives at Amneal Pharmaceuticals Inc include Exec VP & Comm Optns Andrew S Boyer , SVP & Chief HR Officer Nikita Shah , and 10 percent owner Tpg Gp A, Llc .

Amneal Pharmaceuticals Inc (AMRX) Insider Trades Summary

Over the past 18 months, Tasos Konidaris made no insider transaction in Amneal Pharmaceuticals Inc (AMRX). Other recent insider transactions involving Amneal Pharmaceuticals Inc (AMRX) include a net sale of 92,013 shares made by Andrew S Boyer , a net sale of 100,000 shares made by Nikita Shah , and a net sale of 38,000 shares made by Deborah M. Autor .

In summary, during the past 3 months, insiders sold 162,711 shares of Amneal Pharmaceuticals Inc (AMRX) in total and bought 0 shares, with a net sale of 162,711 shares. During the past 18 months, 230,013 shares of Amneal Pharmaceuticals Inc (AMRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 230,013 shares.

Amneal Pharmaceuticals Inc (AMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amneal Pharmaceuticals Inc Insider Transactions

No Available Data

What does Pernix Therapeutics Holdings Inc do?

Who are the key executives at Pernix Therapeutics Holdings Inc?

Tasos Konidaris is the director of Pernix Therapeutics Holdings Inc. Other key executives at Pernix Therapeutics Holdings Inc include SVP & CBO & Principal Fin Off Angus W. Smith , VP of Fin & PAO & Controller Glenn Whaley , and director & President and CFO Graham G Miao .

Pernix Therapeutics Holdings Inc (PTXTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pernix Therapeutics Holdings Inc (PTXTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pernix Therapeutics Holdings Inc (PTXTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pernix Therapeutics Holdings Inc (PTXTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pernix Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Delcath Systems Inc do?

Who are the key executives at Delcath Systems Inc?

Tasos Konidaris is the director of Delcath Systems Inc. Other key executives at Delcath Systems Inc include See Remarks Vojo Vukovic , director & Chief Executive Officer Gerard J Michel , and See Remarks Sandra Pennell .

Delcath Systems Inc (DCTH) Insider Trades Summary

Over the past 18 months, Tasos Konidaris made no insider transaction in Delcath Systems Inc (DCTH). Other recent insider transactions involving Delcath Systems Inc (DCTH) include a net purchase of 100,000 shares made by Vojo Vukovic , a net purchase of 40,000 shares made by David L. Hoffman , and a net purchase of 34,000 shares made by Gerard J Michel .

In summary, during the past 3 months, insiders sold 0 shares of Delcath Systems Inc (DCTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Delcath Systems Inc (DCTH) were sold and 282,819 shares were bought by its insiders, resulting in a net purchase of 282,819 shares.

Delcath Systems Inc (DCTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Delcath Systems Inc Insider Transactions

No Available Data

Tasos Konidaris Mailing Address

Above is the net worth, insider trading, and ownership report for Tasos Konidaris. You might contact Tasos Konidaris via mailing address: 103 Jfk Parkway, Short Hills Nj 07078.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.